Related posts
TSX rebounds, Wall Street choppyMild gains, Charlie Munger diesStocks, yields climb, oil flatThis summary was created by AI, based on 7 opinions in the last 12 months.
Experts have mixed opinions about GE HealthCare Technologies Inc. Some like it despite analyst hate, while others are concerned about its performance in China. However, there seems to be a belief in its strong long-term prospects, particularly in the healthcare-AI sector. The stock is perceived as being undervalued with solid cash flow and potential for growth, but some caution is advised due to its debt. Overall, the company's use of AI in their MRIs and the successful management of their Aerospace division are highlighted as positive factors.
Are his favourite healthcare-AI play.
They've been hurt by China, but had a decent quarter. He bought the weakest of the three GE companies. He will ultimately make money on this.
GE did a great job managing their Aerospace division, including its debt, then spinning it off. He owns no GE division, but like the healthcare division the most. Is a little concerned with their debt, but trades at 18x with solid cash flow and has solid prospects.
He likes all three GE companies, but this is his favourite, because he likes their strategy of using AI in their MRIs.
One of the GE spinoffs. Larry Culp did a fantastic job turning GE around. Priced aggressively. Attractive at 10-15% below where it is now.
He owns a big position. Likes this a lot and it's doing many great things. It's so cheap. Is sticking with this long-term. Likes their business which is MRIs.
Spinoff from GE parent. Not buying shares at this time. Waiting to see how management performs. Strong sector (healthcare), but performance remains to be seen.
Spun out from GE. He's been buying it this year and holds a large position. They reported a great beat in late July. Eventually, GEHC will decouple from the rest of healthcare which has been lagging. (Maybe Wall St is nervous about Washington taking shots at healthcare in the election year coming up.) Shares are down 12% this month, and this is a cheap, great opportunity.
This GE health spin-off's equipment will be in big demand next year when doctors conduct MRIs to measure plaque in the brain (to determine which patients get the new Alzheimer's drug). Huge demand. Why are shares down 12 points since their report. Makes no sense. He bought more shares to average down.
Getting good reviews. He's done some research into it. It's screening quite well, there's some opportunity here. A good healthcare offering.
He's been buying it. You will need an MRI before you can get into an Alzheimer's program. GEHC will have to talk about AI in their business when they report next week.
He bought it last week. Has more room to run. Spunoff by GE to start the year. Is up 35% YTD. Their scanners catch Alzheimer's. He's bullish on medical devices. Trades at 18x 2024 PE. Is in a slight pullback now.
GE HealthCare Technologies Inc is a American stock, trading under the symbol GEHC-Q on the NASDAQ (GEHC). It is usually referred to as NASDAQ:GEHC or GEHC-Q
In the last year, 6 stock analysts published opinions about GEHC-Q. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for GE HealthCare Technologies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
6 stock analysts on Stockchase covered GE HealthCare Technologies Inc In the last year. It is a trending stock that is worth watching.
On 2024-12-05, GE HealthCare Technologies Inc (GEHC-Q) stock closed at a price of $81.565.
Trades at 21x PE. It's hated by analysts, but he likes it. Wait for another downgrade before entering.